2025-08-30 04:54:19
Latest Post
Himadri Speciality Chemical Ltd Secures ISCC PLUS Certification
HCLSoftware delivers Digital Independence with AI-Powered Sovereign Collaboration Solutions for Business-Critical Infrastructure
Dr. Agarwal's Health Care Limited and Dr. Agarwal's Eye Hospital Limited announce Merger
SAMHI signs agreement to Lease for ~260-room Mid-Scale Hotel in Hyderabad's Financial District
Rail Vikas Nigam Ltd signs JV agreement with Texmaco Rail & Engineering Ltd
Stock Report
Venus Remedies Ltd consolidated Q2FY22 profit jumps to Rs. 23.14 crore
Posted On : 2021-11-04 22:00:17( TIMEZONE : IST )
Venus Remedies Limited has reported Consolidated financial results for the period ended September 30, 2021.
Financial Results (Q2 FY2022) - QoQ Comparison
The company has reported total income of Rs. 205.45 crores during the period ended September 30, 2021 as compared to Rs. 131.765 crores during the period ended June 30, 2021.
The company has posted net profit / (loss) of Rs. 23.148 crores for the period ended September 30, 2021 as against net profit / (loss) of Rs. 11.697 crores for the period ended June 30, 2021.
The company has reported EPS of Rs. 17.32 for the period ended September 30, 2021 as compared to Rs. 8.86 for the period ended June 30, 2021.
| Financials | Q2 FY2022 | Q1 FY2022 | % Change |
| Total Income | ₹ 205.45 crs | ₹131.765 crs |  55.92% |
| Net Profit | ₹23.148 crs | ₹11.697 crs | 97.90% |
| EPS | ₹17.32 | ₹8.86 | 95.49% |
Financial Results (Q2 FY2022) - YoY Comparison
The company has reported total income of Rs. 205.45 crores during the period ended September 30, 2021 as compared to Rs.138.345 crores during the period ended September 30, 2020.
The company has posted net profit / (loss) of Rs.23.148 crores for the period ended September 30, 2021 as against net profit / (loss) of Rs.13.026 crores for the period ended September 30, 2020.
The company has reported EPS of Rs.17.32 for the period ended September 30, 2021 as compared to Rs.10.55 for the period ended September 30, 2020.
| Financials | Q2 FY2022 | Q2 FY2021 | % Change |
| Total Income | ₹ 205.45 crs | ₹138.345 crs | 48.51% |
| Net Profit | ₹23.148 crs | ₹13.026 crs | 77.71% |
| EPS | ₹17.32 | ₹10.55 | 64.17% |
Financial Results (Half Year Ended FY2022) - YoY Comparison
The company has reported total income of Rs.337.215 crores during the 6 Months period ended September 30, 2021 as compared to Rs.329.125 crores during the 6 Months period ended September 30, 2020.
The company has posted net profit / (loss) of Rs.34.846 crores for the 6 Months period ended September 30, 2021 as against net profit / (loss) of Rs.14.999 crores for the 6 Months period ended September 30, 2020.
The company has reported EPS of Rs.26.41 for the 6 Months period ended September 30, 2021 as compared to Rs.12.15 for the 6 Months period ended September 30, 2020.
| Financials | Half Year Ended FY2022 | Half Year Ended FY2021 | % Change |
| Total Income | ₹337.215 crs | ₹329.125 crs | 2.46% |
| Net Profit | ₹34.846 crs | ₹14.999 crs | 132.32% |
| EPS | ₹26.41 | ₹12.15 | 117.37% |
Shares of Venus Remedies Limited was last trading in BSE at Rs. 525.65 as compared to the previous close of Rs. 544.90. The total number of shares traded during the day was 12799 in over 863 trades.
The stock hit an intraday high of Rs. 544.95 and intraday low of 520.10. The net turnover during the day was Rs. 6752694.00.
